Skip to main content
Clinical Trials/CTRI/2023/03/050705
CTRI/2023/03/050705
Not yet recruiting
未知

Effect of Proprioceptive Neuromuscular Facilitation Technique and TENS on Lower Limb sensorimotor Function, Balance and Quality of life in Chemotherapy Induced Peripheral Neuropathy in Gynecological Cancer â?? A Randomized Control Trial.

Datta Meghe Institute of Higher Education and Research0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: G652- Sequelae of toxic polyneuropathy
Sponsor
Datta Meghe Institute of Higher Education and Research
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Datta Meghe Institute of Higher Education and Research

Eligibility Criteria

Inclusion Criteria

  • 1\)Newly diagnosed patient with stages I to III gynecologic cancers including ovarian, uterine, and cervical cancer planning to receive definitive number of platinum based compounds chemotherapy.
  • 2\)Patients who are given Taxanes and Platinum based compounds â?? Cisplastin, Carboplatin and Oxaliplatin
  • 3\)Patients having Grade I or II peripheral neuropathy according to National Cancer Institute â??common toxicity criteria
  • 4\)Planned to receive a minimum of 4 cycles of chemotherapy treatment with either of the chemotherapy agents (Platinum based compound)
  • 5\)Women between 50 to 70 years.

Exclusion Criteria

  • 1\)Male Patient
  • 2\)Patients having Pre existing peripheral nerve injury.
  • 3\)Patient with Type 2 Diabetes Mellitus ,Autoimmune and Inflammatory disorders
  • 4\)Patient having Grade III, IV, V peripheral neuropathy according to National Cancer Institute â?? common toxicity criteria suggesting that patient requiring assistive device are excluded.
  • 5\)Previous exposure to any of the implicated chemotherapy agents within last 5 years that could potentially cause peripheral neuropathy.
  • 6\)Stage IV cancer
  • 7\)Patients having any metal implants.
  • 8\)Patients with Artificial Pacemaker.
  • 9\)Patient having any traumatic Injury to the lower limb.

Outcomes

Primary Outcomes

Not specified

Similar Trials